This message was sent to ##Email##
Advertisement
|
|
|
|
| |
We're just two weeks away from launching our new member benefit — ITNS Central, our online community — and we can't wait for you to get access!
But you might be wondering, "What exactly can I do in this online space?" Well, here are just a few of the ways you can participate:
Ask Questions of Your Peers
Start discussions with fellow ITNS members by creating posts that your peers can provide their thoughts on - anywhere and anytime!
Share Important Resources
Have a document or incredible resource that you think others would benefit from? ITNS Central is a perfect place to share it.
Get and Give Answers
See a question that you know the answer to? You can use ITNS Central to provide your thoughts!
Look out for future emails, where we walk through more ITNS Central features you can use to engage with and learn from your fellow ITNS members!
Medical Xpress
Long-delayed rules that will more broadly share scarce donated livers went into effect Feb. 3, to the dismay of some hospitals in Tennessee, Kansas and other states that fear their patients may lose out. Under the new policy, patients near death within 500 nautical miles (575 miles) of a donor hospital will be offered a matching liver first. If there are no takers, it will be offered next to progressively less sick patients at different distances within that circle.
The flip side: Patients that aren't as sick living in areas where there are more organ donors, such as parts of the South and Midwest, likely will wait longer as livers once used locally are shipped to urban centers where the shortage is more severe.
READ MORE
American Journal of Transplantation via Wiley Online Library
Disparities in organ acceptance practices exacerbate donor heart nonuse and lead to increased waiting times and mortality for heart transplant candidates. Researchers studied disparities in donor heart acceptance among U.S. transplant centers and their relations to posttransplant outcomes.
READ MORE
 |
|
Promoted by
Veloxis Pharmaceuticals
Follow the journeys of kidney transplant patients who transitioned to a different immunosuppression regimen. After talking with their doctors about their experiences with other options, they decided to make a switch.
Watch video
|
|
Healio
A recent study published in the Annals of Thoracic Surgery found that cardiac allografts from high-risk donors implanted in children resulted in similar posttransplant survival as those from low-risk donors.
READ MORE
American College of Surgeons via Medical Xpress
Virtual antibody crossmatching is a safe and efficient way of selecting kidney transplant recipients. Two years after implementing the process, the Medical University of South Carolina division of transplant surgery, Charleston, concluded that the technique was just as accurate and sensitive as physical crossmatch, the current gold standard, and much quicker.
READ MORE
Advertisement
Veloxis Pharmaceuticals
Did you know there’s a transplant support system to help patients and providers with best-in-class assistance and resources? This ongoing support system assists with benefit investigation, prior authorization assistance, coordination with specialty pharmacies, prescription fulfillment navigation, and CoverMyMeds® access. There’s also a $0 co-pay card to overcome financial barriers.
Find out more
|
BioSpace
The teen who had a double lung transplant after a vaping-related injury is sharing his story in hopes to inspire others – particularly teens – to stop vaping and seek alternatives for a healthier and happier life. Daniel Ament was 16 years old when Henry Ford Health System Cardio-thoracic surgeon Dr. Hassan Nemeh and his team at the Henry Ford Transplant Institute performed the transplant on Oct. 15, 2019 at Henry Ford Hospital in Detroit. It is thought to be the first double lung transplant in the world for a patient suffering what the U.S. Centers for Disease Control and Prevention calls EVALI, or E-cigarette or vaping-associated lung injury.
READ MORE
The Journal of Heart and Lung Transplantation via MD Linx
Given the possible value of calcium channel blockers in ameliorating the decline in renal function caused by calcineurin inhibitors in lung transplant recipients, researchers here investigated if the decline in glomerular filtration rate in LTX recipients could be reduced with preoperative and 12-week postoperative treatment with the calcium channel blocker, felodipine.
READ MORE
JAMA via MD Linx
The present study intended to correlate generic health-related quality of life between solid organ transplant recipients with and without Keratinocyte carcinoma and explored variables associated with KC-specific HRQoL in solid organ transplant recipients using the Basal and Squamous Cell Carcinoma Quality of Life.
READ MORE
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
